Symphogen's Seed VC Round

Symphogen raised a round of funding on , . Investors include Sunshine Capital.

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the fr…

Articles about Symphogen's Seed VC Round: